National conference with a focus on ATMP
The national conference ATMP Sweden 2022 Stockholm takes place on 7-8 November. The conference begins with a half-day of seminar and study visit in Flemingsberg.
The network ATMP Sweden invites you to the conference with support from the innovation environment “ATMP 2030” and the competence center Center for Advanced Medical Products (CAMP).
During the first day on 7 November, at 13-16, participants are welcome to Flemingsberg to take part in the area’s ATMP activities, research and networking around the operations. There is also the opportunity to participate in guided tours at selected facilities within KI Campus Flemingsberg and Karolinska University Hospital in Huddinge.
The second day of the conference on 8 November is a full day in Solna, at 9-16, with a national focus on the ATMP ecosystem in Sweden. The Swedish network of actors and stakeholders within ATMP gathers here to stimulate knowledge sharing and collaboration.
Participation during the conference days is free. On 7 November, afternoon tea is also included, and on 8 November both lunch and pre- and afternoon tea are included.
See more info and program here ATMP – ATMP Sweden 2022 Stockholm
Register here ATMP – Registration links (atmpsweden.se)
Do you have questions? Contact kristina.kannisto@regionstockholm.se or hanna.sjölund@ki.se
Please note that the program on 7 November is in English, while the program on 8 November is in Swedish.
BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development
As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.
Sally Sow and Turn UP: Winners of the Flemingsberg Science Award IDEA 2024
The music world can be a challenging place, both for organizers trying to reach their audience and for music lovers searching for events that suit their taste. Sally Sow, the winner of the Flemingsberg Science Award IDEA 2024, has developed Turn Up, a platform that simplifies organizing, discovering, and participating in local music events. With a focus on inclusion and accessibility, she aims to create a music scene where everyone feels welcome.
KTH’s Technical Preparatory Year Moves to Flemingsberg – Student Numbers Expected to Double in Autumn 2025
In the autumn of 2025, KTH will relocate its Technical Preparatory Year spots from Södertälje to Flemingsberg, resulting in a significant increase in student numbers at Campus Flemingsberg. By nearly doubling available seats and introducing a new learning center model in collaboration with 3 municipalities, KTH aims to meet the growing demand for technical education in the region.
Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps
Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.
OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.
